# Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.

> **NCT01051882** · PHASE1,PHASE2 · COMPLETED · sponsor: **Brainstorm-Cell Therapeutics** · enrollment: 12 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **BIOLOGICAL:** MSC-NTF cells transplantation (IM)
- **BIOLOGICAL:** MSC-NTF cells transplantation (IT)

## Key facts

- **NCT ID:** NCT01051882
- **Lead sponsor:** Brainstorm-Cell Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-12
- **Final completion:** 2013-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01051882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01051882, "Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01051882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*